Latest Breaking News On - Eric soyer - Page 1 : comparemela.com

PHAXIAM provides Business and Financial Update for the First Quarter of 2024

PHAXIAM provides Business and Financial Update for the First Quarter of 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomEric soyerPharma bioEnregistrement universelArthur rouillFirst quarterChief executive officerProsthetic joint infectionsEndocarditis infectionsDiabetic food ulcerUrinary tract severe infectionsJoint infectionsClinical trial applicationFoot ulcerInvestigator sponsored trial

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomArthur rouillEric soyerEnregistrement universelPharma bioDennis riedlUniversal registration documentDes marchNext biotechFrench autoritRegistration document

PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)

PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomEric soyerArthur rouillPharma bioEnregistrement universelUniversal registration documentDes marchNext biotechFrench autoritRegistration document

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalNew yorkUnited statesUnited kingdomPharma bioArthur rouillEnregistrement universelEric soyerStefan klotterCompany securitiesReceipt administrationExchange commissionSecurities exchangeCompany annual report on formAmerican depositary sharesNasdaq capital market

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Lyon and Cambridge , March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics , a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today.

France generalUnited statesUnited kingdomNew yorkEric soyerPharma bioEnregistrement universelArthur rouillCompany annual report on formAdss for the companySecurities exchangeCompany securitiesExchange commissionReceipt administrationAmerican depositary sharesNasdaq capital market